These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10953327)

  • 1. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
    Pu QQ; Bezwoda WR
    Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma.
    Friedman HS; Skapek SX; Colvin OM; Elion GB; Blum MR; Savina PM; Hilton J; Schold SC; Kurtzberg J; Bigner DD
    Cancer Res; 1988 Oct; 48(19):5397-402. PubMed ID: 3416297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.
    Panasci L; Paiement JP; Christodoulopoulos G; Belenkov A; Malapetsa A; Aloyz R
    Clin Cancer Res; 2001 Mar; 7(3):454-61. PubMed ID: 11297233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity.
    Robson CN; Lewis AD; Wolf CR; Hayes JD; Hall A; Proctor SJ; Harris AL; Hickson ID
    Cancer Res; 1987 Nov; 47(22):6022-7. PubMed ID: 3664506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
    Schecter RL; Alaoui-Jamali MA; Woo A; Fahl WE; Batist G
    Cancer Res; 1993 Oct; 53(20):4900-6. PubMed ID: 8402679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia.
    Panasci L; Henderson D; Torres-Garcia SJ; Skalski V; Caplan S; Hutchinson M
    Cancer Res; 1988 Apr; 48(7):1972-6. PubMed ID: 3349471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
    Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.
    Batist G; Torres-Garcia S; Demuys JM; Greene D; Lehnert S; Rochon M; Panasci L
    Mol Pharmacol; 1989 Aug; 36(2):224-30. PubMed ID: 2770701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV; Ji M; Khan SH; Bloomer WD
    Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
    Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
    Parsons PG; Carter FB; Morrison L; Regius Mary Sister
    Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a melphalan-resistant human multiple myeloma cell line.
    Bellamy WT; Dalton WS; Gleason MC; Grogan TM; Trent JM
    Cancer Res; 1991 Feb; 51(3):995-1002. PubMed ID: 1988143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation.
    Murray D; Meyn RE
    Cancer Res; 1986 May; 46(5):2324-9. PubMed ID: 3697977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.